Winfried Willinek

Winfried Willinek

Auto-generated profile, based on publicly available information

Winfried Willinek

Department of Radiology, Neuroradiology, Sonography and Nuclear Medicine, Hospital of the Barmherzige Brüder Trier, Nordallee 1, 54292 Trier, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in European Journal of Radiology
Verified
Journal Article
Closed access
MMMichael Meier-Schroers
Michael Meier-Schroers
GKGuido Kukuk
Guido Kukuk
KWKarsten Wolter
Karsten Wolter
GDGeorges Decker
Georges Decker
SFStefan Fischer
Stefan Fischer
WWWinfried Willinek
Winfried Willinek

11 January 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
DLDieter Lütjohann
Dieter Lütjohann
MMMilka Marinova
Milka Marinova
KWKarsten Wolter
Karsten Wolter
WWWinfried Willinek
Winfried Willinek
NBNorman Bitterlich
Norman Bitterlich
FSFrans Stellaard
Frans Stellaard
Chitosan treatment results in significantly lower serum low density lipoprotein (LDL) cholesterol concentrations. To assess the working mechanisms of chitosan, we measured serum surrogate markers of cholesterol absorption (campesterol, sitosterol, cholestanol), synthesis (lathosterol, lanosterol, desmosterol), and degradation to bile acids (7α-hydroxy-cholesterol, 27-hydroxy-cholesterol), corrected for cholesterol concentration (R_sterols). Over 12 weeks, 116 obese subjects (Body Mass Index, BMI 31.7, range 28.1–38.9 kg/m2) were studied under chitosan (n = 61) and placebo treatments (n = 55). The participants were briefly educated regarding improvement of nutrition quality and energy expenditure. Daily chitosan intake was 3200 mg. Serum LDL cholesterol concentration decreased significantly more (p = 0.0252) under chitosan (−8.67 ± 18.18 mg/dL, 5.6%) than under placebo treatment (−1.00 ± 24.22 mg/dL, 0.9%). This reduction was not associated with the expected greater decreases in markers of cholesterol absorption under chitosan treatment. Also, increases in markers of cholesterol synthesis and bile acid synthesis under chitosan treatment were not any greater than under placebo treatment. In conclusion, a significant selective reduction of serum LDL cholesterol under chitosan treatment is neither associated with a reduction of serum surrogate markers of cholesterol absorption, nor with increases of markers for cholesterol and bile acid synthesis.

1 July 2014 in Investigative Radiology
Verified
Journal Article
Closed access
DHDariusch Reza Hadizadeh
Dariusch Reza Hadizadeh
GJGregor Jošt
Gregor Jošt
HPHubertus Pietsch
Hubertus Pietsch
MWMartin Weibrecht
Martin Weibrecht
MPMichael Perkuhn
Michael Perkuhn
WWWinfried Albert Willinek
Winfried Albert Willinek
The concentration and relaxivities of contrast agents affect quantitative and qualitative image quality in contrast-enhanced time-resolved 4-dimensional magnetic resonance angiography (4D-MRA). Gadobutrol has a high relaxivity and is the only gadolinium (Gd)-based contrast agent approved for clinical use at a 1 M concentration. This promises to confer superior bolus characteristics by generating a steeper and shorter bolus with a higher peak Gd concentration. The purpose of this study was to quantitatively examine bolus characteristics of 1 M gadobutrol compared with 0.5 M gadopentetate dimeglumine and to evaluate image quality in thoracoabdominal 4D-MRA. A total of 7 Goettingen minipigs received dynamic computed tomography (CT) on a clinical 64-slice CT (transverse slices, 80 kV, 20 seconds, 0.3 s/dynamic frame) and 4D-MRA (time-resolved imaging with stochastic trajectories; 1. transverse slices, 30 seconds, 0.49 s/frame; 2. coronal slices, 70 seconds, 1.3 s/frame) on a 1.5-T clinical whole-body magnetic resonance imaging under general anesthesia using gadopentetate dimeglumine and gadobutrol in an intraindividual comparative study. Computed tomography attenuations were converted into Gd concentrations on the basis of previous phantom experiments. Quantitative analysis included measurements of the full width at half maximum, time-to-peak intervals, and peak of each bolus in dynamic CT and transverse 4D-MRA. These studies were carried out at equivalent contrast agent flow rates of 1 mL/s. Quantitative analysis (7 arteries and veins) and qualitative image analysis were performed on coronal thoracoabdominal 4D-MRA studies carried out at flow rates of 1 mL/s and, in the case of gadopentetate dimeglumine, also at molarity-adjusted flow rates of 2 mL/s. The bolus in both transverse 4D-MRA and dynamic CT was significantly narrower (full width at half maximum), earlier (time to peak), and higher (signal intensity enhancement in 4D-MRA, Gd concentration in dynamic CT) when using gadobutrol instead of gadopentetate dimeglumine at a flow rate of 1.0 mL/s (P = 0.008-< 0.0001). In thoracoabdominal 4D-MRA, the signal intensity level and overall image quality were highest in examinations with gadobutrol, followed by examinations with gadopentetate dimeglumine at flow rates of 2 mL/s, and lowest in examinations with gadopentetate dimeglumine at flow rates of 1 mL/s. A more compact bolus shape was observed after administration of gadobutrol compared with gadopentetate dimeglumine in minipigs. This was demonstrated both in 4D-MRA, where Gd concentration, relaxivity, and the image-acquisition technique play a role, and in CT, where the signal intensity depends only on the Gd concentration. The overall image quality was rated higher in examinations with 1.0 M gadobutrol than with 0.5 M gadopentetate dimeglumine.

11 September 2015 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
CPClaus Christian Pieper
Claus Christian Pieper
DTDaniel Thomas
Daniel Thomas
JNJennifer Nadal
Jennifer Nadal
WWWinfried A. Willinek
Winfried A. Willinek
HSHans Heinz Schild
Hans Heinz Schild
CMCarsten Meyer
Carsten Meyer

1 December 2016 in European Journal of Radiology
Verified
Journal Article
Closed access
MMMichael Meier-Schroers
Michael Meier-Schroers
RHRami Homsi
Rami Homsi
GKGuido Kukuk
Guido Kukuk
KWKarsten Wolter
Karsten Wolter
GDGeorges Decker
Georges Decker
WWWinfried Willinek
Winfried Willinek